血管区域靶向血运重建在侧支血管存在下的系统评价与荟萃分析
该系统评价与荟萃分析纳入21项研究共4252条肢体,比较直接血运重建(DR)、间接血运重建(IR)及经侧支间接血运重建(IRc)对下肢创面愈合、大截肢、再干预和全因死亡的影响。结果显示DR和IRc在创面愈合率和大截肢率上均显著优于IR,DR为大截肢率最优,但DR与IRc在创面愈合上无显著差异。
要点
- DR和IRc的创面愈合率显著优于IR,DR与IRc间无显著差异。
- DR的大截肢率显著优于IR和IRc,IRc也显著优于IR。
- 三组全因死亡率无显著差异,DR与IR再干预率无显著差异。
核心结论
- 在重症肢体缺血治疗中,DR和IRc的创面愈合率和大截肢率均显著优于IR。
- DR应作为首选血运重建方式,但当DR不可行时IRc可提供相当结局。
研究设计与样本
- 遵循PRISMA指南的系统评价与荟萃分析,检索Ovid MEDLINE,纳入21项研究共4252条肢体(DR 2231条,IR 1647条,IRc 270条)。
- 采用Newcastle-Ottawa量表评估研究质量,使用随机效应模型计算比值比(OR)。
临床怎么用
- 对于下肢创面合并重症肢体缺血患者,优先考虑直接血运重建(DR)以降低大截肢风险。
- 当直接血运重建不可行时,经侧支间接血运重建(IRc)可作为替代选择以改善创面愈合和保肢。
局限性
- IRc肢体样本量较小。
- 纳入研究以回顾性研究为主。
- 各研究间结局定义存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endovascular procedures for targeted treatment of lower extremity wounds can be subdivided as direct revascularization (DR), indirect revascularization (IR), and IR via collateral flow (IRc). Although previous systematic reviews assert superiority of DR when compared with IR, the role of collateral vessels in clinical outcomes remains to be defined. This systematic review and meta-analysis aims to define the usefulness of DR, IR, and IRc in treatment of lower extremity wounds with respect to (1) wound healing, (2) major amputation, (3) reintervention, and (4) all-cause mortality. METHODS: A meta-analysis was performed in accordance with PRISMA guidelines. Ovid MEDLINE was queried for records pertaining to the study question using appropriate Medical Subject Heading terms. Studies were limited to those using DR, IR, or IRc as a primary intervention and reporting information on at least one of the primary outcomes of interest. No limitation was placed on year of publication, country of origin, or study size. Studies were assessed for validity using the Newcastle-Ottawa Scale. Study characteristics and patient demographics were collected. Data representing the primary outcomes-wound healing, major amputation, reintervention, and all-cause mortality-were collected for time points ranging from one month to four years following intervention. A meta-analysis on sample size-weighted data assuming a random effects model was performed to calculate odds ratios (ORs) for the four primary outcomes at various time points. RESULTS: We identified 21 studies for a total of 4252 limbs (DR, 2231; IR, 1647; IRC, 270). Overall wound healing rates were significantly superior for DR (OR, 2.45; P = .001) and IRc (OR, 8.46; P < .00001) compared with, IR with no significant difference between DR and IRc (OR, 1.25; P = .23). The overall major amputation rates were significantly superior for DR (OR, 0.48; P < .00001) and IRc (OR, 0.44; P = .006) compared with IR, with DR exhibiting significantly improved rates compared with IRc (OR, 0.51; P = .01). The overall mortality rates showed no significant differences between DR (OR, 0.89; P = .37) and IRc (OR, 1.12; P = .78) compared with IR, with no significant difference between DR and IRc (OR, 0.54; P = .18). The overall reintervention rates showed no significant difference between DR and IR (OR, 1.05; P = .81), with no studies reporting reintervention outcomes for IRc. CONCLUSIONS: Both DR and IRc offer significantly improved wound healing rates and major amputation rates compared with IR when used to treat critical limb ischemia. Although DR should be the preferred method of revascularization, IRc can offer comparable outcomes when DR is not possible. This analysis was limited by a small sample size of IRc limbs, a predominance of retrospective studies, and variability in outcome definitions between studies.
引用
- Kim KG, Meshkin DH, Tirrell AR, et al. A systematic review and meta-analysis of endovascular angiosomal revascularization in the setting of collateral vessels. J Vasc Surg. 2021. PMID: 33940077. doi:10.1016/j.jvs.2021.04.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。